A carregar...
Cardiovascular outcomes of liraglutide in patients with type 2 diabetes: A systematic review and meta-analysis
BACKGROUND: Liraglutide is a novel, long-acting glucagon-like peptide-1 (GLP-1) analogue used to treat type 2 diabetes mellitus. However, the cardiovascular safety and benefits of liraglutide treatment on type 2 diabetes patients remain in debate. In this study, we aimed to examine the overall cardi...
Na minha lista:
| Publicado no: | Medicine (Baltimore) |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wolters Kluwer Health
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6867782/ https://ncbi.nlm.nih.gov/pubmed/31725627 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000017860 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|